- Home
- CCI vs EW Comparison
CCI vs EW Comparison
Compare CCI & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCI
- EW
- Stock Information
- Founded
- CCI 1994
- EW 1958
- Country
- CCI United States
- EW United States
- Employees
- CCI N/A
- EW N/A
- Industry
- CCI Real Estate Investment Trusts
- EW Industrial Specialties
- Sector
- CCI Real Estate
- EW Health Care
- Exchange
- CCI Nasdaq
- EW Nasdaq
- Market Cap
- CCI 45.5B
- EW 45.5B
- IPO Year
- CCI 1998
- EW 2000
- Fundamental
- Price
- CCI $94.41
- EW $76.72
- Analyst Decision
- CCI Buy
- EW Buy
- Analyst Count
- CCI 17
- EW 17
- Target Price
- CCI $120.53
- EW $86.29
- AVG Volume (30 Days)
- CCI 3.0M
- EW 4.8M
- Earning Date
- CCI 10-15-2025
- EW 10-23-2025
- Dividend Yield
- CCI 4.47%
- EW N/A
- EPS Growth
- CCI N/A
- EW 188.09
- EPS
- CCI N/A
- EW 7.02
- Revenue
- CCI $6,468,000,000.00
- EW $5,685,100,000.00
- Revenue This Year
- CCI N/A
- EW $13.23
- Revenue Next Year
- CCI $2.93
- EW $9.76
- P/E Ratio
- CCI N/A
- EW $32.03
- Revenue Growth
- CCI 16.29
- EW 9.14
- 52 Week Low
- CCI $84.20
- EW $64.01
- 52 Week High
- CCI $115.89
- EW $83.00
- Technical
- Relative Strength Index (RSI)
- CCI 42.76
- EW 47.32
- Support Level
- CCI $94.82
- EW $76.48
- Resistance Level
- CCI $97.05
- EW $78.37
- Average True Range (ATR)
- CCI 1.58
- EW 1.81
- MACD
- CCI 0.34
- EW 0.24
- Stochastic Oscillator
- CCI 51.79
- EW 67.48
About CCI Crown Castle Inc.
Crown Castle owns and leases roughly 40,000 cell towers in the United States. It also owns more than 90,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. Crown Castle's towers and fiber are predominantly in the largest US cities. The company has a very concentrated customer base, with about 75% of its revenue from the Big Three US mobile carriers. Crown Castle operates as a real estate investment trust. It has announced plans to divest its fiber business, which should be finalized in 2026. After that, Crown will be a stand-alone tower operator.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.